ANN-004

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameANN-004
Drug Alias Nameadeno-associated virus based gene therapy (Annapurna)gene therapy (Weill Medical College of Cornell University)gene therapy (Annapurna)ANN-004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunoglobulin E inhibitors
TargetsImmunoglobulin E
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeill Medical College of Cornell University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnnapurna Therapeutics LtdWeill Medical College of Cornell UniversityAdverum Biotechnologies Inc
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A